passlisted in Coinbase#9 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 2
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 14:17 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 1 time across 8 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
calc irae diabetes first appeared in TOLL's pulls on 2026-09-28.
At api.magentlab.com, calc irae diabetes takes POST requests, is listed in the Coinbase registry, and falls under the "other" category by TOLL's rules.
calc irae diabetes is priced at 0.005 USDC on Base.
Its declared inputs are a JSON body with the field items.
calc irae diabetes answered the sweep of 2026-10-01 with a valid 402, as at every sweep since 2026-09-28.
A response from calc irae diabetes, as declared, includes path, count and items.
calc irae diabetes shares api.magentlab.com with 843 other listed endpoints and is tied 9th by calls with 248 others.
calc irae diabetes drew 2 calls from one payer in the trailing 30 days.
The last call to calc irae diabetes came 3 days before the snapshot, 2026-09-28.
Closest in price to calc irae diabetes within the "other" category: enrich profile at win.oneshotagent.com and ping at www.api-xpay.com.
calc irae diabetes is priced above 46% of comparable listings in the "other" category.
The wallet paid by calc irae diabetes is the payee of 844 endpoints on one host.
The seller's own tags are irae-diabetes, glucose, checkpoint and asco.
The price of calc irae diabetes is declared by 739 other listings in the "other" category too.
the payment options, as of 2026-10-01 05:50 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-10-01 07:14 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-10-01 07:14 UTC | pass | 0 | daily-2026-10-01 |
| 2026-09-30 06:31 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 18:51 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:54 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 16:40 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 14:17 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"t1dm": false,
"ketosis": false,
"glucose_mg_dl": 140,
"life_threatening": false,
"severe_unable_adl": false
},
{
"t1dm": false,
"ketosis": false,
"glucose_mg_dl": 140,
"life_threatening": false,
"severe_unable_adl": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/irae_diabetes",
"count": 2,
"items": [
{
"t1dm": false,
"grade": 1,
"formula": "irae_diabetes",
"ketosis": false,
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "life_threatening"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_500"
},
{
"met": false,
"factor": "severe_unable_adl"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_250"
},
{
"met": false,
"factor": "ketosis"
},
{
"met": false,
"factor": "t1dm"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_160"
},
{
"met": true,
"value": 140,
"factor": "glucose_gt_99"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"icpi_action": "continue",
"glucose_mg_dl": 140,
"life_threatening": false,
"severe_unable_adl": false,
"formula_expression": "irae_diabetes first-match worst-wins (Brahmer 2018 Table 4.4 fasting glucose mg/dL): grade 4 if life_threatening or glucose_mg_dl > 500; else grade 3 if severe_unable_adl or glucose_mg_dl > 250; else grade 2 if ketosis or t1dm or glucose_mg_dl > 160; else grade 1 if glucose_mg_dl > 99; else grade 0. icpi_action continue (0-1), hold_until_control (2), hold_admit (3-4). mg/dL only. Not DKA diagnostic criteria as a separate instrument. magent does not assay glucose. Not a diagnosis. Not an insulin dose"
},
{
"t1dm": false,
"grade": 1,
"formula": "irae_diabetes",
"ketosis": false,
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "life_threatening"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_500"
},
{
"met": false,
"factor": "severe_unable_adl"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_250"
},
{
"met": false,
"factor": "ketosis"
},
{
"met": false,
"factor": "t1dm"
},
{
"met": false,
"value": 140,
"factor": "glucose_gt_160"
},
{
"met": true,
"value": 140,
"factor": "glucose_gt_99"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"icpi_action": "continue",
"glucose_mg_dl": 140,
"life_threatening": false,
"severe_unable_adl": false,
"formula_expression": "irae_diabetes first-match worst-wins (Brahmer 2018 Table 4.4 fasting glucose mg/dL): grade 4 if life_threatening or glucose_mg_dl > 500; else grade 3 if severe_unable_adl or glucose_mg_dl > 250; else grade 2 if ketosis or t1dm or glucose_mg_dl > 160; else grade 1 if glucose_mg_dl > 99; else grade 0. icpi_action continue (0-1), hold_until_control (2), hold_admit (3-4). mg/dL only. Not DKA diagnostic criteria as a separate instrument. magent does not assay glucose. Not a diagnosis. Not an insulin dose"
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-01 05:50 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc irae diabetes on api.magentlab.com", snapshot of 2026-10-01 05:50 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-irae-diabetes-3f92cf/at/2026-10-01T05-50Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-irae-diabetes-3f92cf-2026-10-01T05-50Z,
author = {TOLL},
title = {calc irae diabetes on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-irae-diabetes-3f92cf/at/2026-10-01T05-50Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-01 05:50 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.